UK Markets close in 5 hrs 8 mins

Anavex Life Sciences CEO discusses trials of new Parkinson's and dementia drugs

In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Yahoo Finance's Myles Udland talks with Anavex Life Sciences CEO Christopher Missling about the company's new Parkinson's disease drugs as well as its recent capital-raising stock sale.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting